Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Moodys
Colorcon
Boehringer Ingelheim
Dow
Queensland Health
Daiichi Sankyo
Accenture

Generated: December 9, 2018

DrugPatentWatch Database Preview

Regulatory Exclusivity: NEW INDICATION

« Back to Dashboard

Drugs with New Indication Regulatory Exclusivity

Click here to include patents covering these drugs in this list

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Exclusivity Expiration Patented / Exclusive Use
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552-001 Nov 13, 2013 RX Yes Yes ➤ Try a Free Trial FOR THE TREATMENT OF PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA
Shire Development VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977-003 Feb 23, 2007 RX Yes Yes ➤ Try a Free Trial MODERATE TO SEVERE BINGE EATING DISORDER (BED)
Shire Development VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977-005 Dec 10, 2007 RX Yes No ➤ Try a Free Trial MODERATE TO SEVERE BINGE EATING DISORDER (BED)
Shire Development VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977-007 Oct 30, 2014 RX Yes No ➤ Try a Free Trial MODERATE TO SEVERE BINGE EATING DISORDER (BED)
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Exclusivity Expiration Patented / Exclusive Use

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Colorcon
Cerilliant
Johnson and Johnson
McKinsey
Harvard Business School
QuintilesIMS
Deloitte
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.